Trial intelligence / Profile preview

PPC with Antiviral Therapy in Hepatitis C

NCT00211848Phase 2Completed

Sponsor
Icahn School of Medicine at Mount Sinai
Start
Jun 2000
Primary completion
Dec 2005
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of polyene phosphatidylcholine in hepatitis C (HCV), Liver Fibrosis (LF), sponsored by Icahn School of Medicine at Mount Sinai. Started Jun 2000; status: completed.

02

Drugs

polyene phosphatidylcholine
03

Conditions

hepatitis C (HCV)Liver Fibrosis (LF)

Beyond the preview

Go deeper on NCT00211848.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00211848.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call